A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis

Publisher Website
Google Scholar
Abstract
The prognosis of patients with systemic lupus erythematosus who have glomerulonephritis is poor, despite treatment with immunosuppressive therapy. Plasmapheresis therapy has been used, but there have been few controlled clinical observations of its efficacy.